Inhibrx Biosciences, Inc. (INBX)
82.21
-2.30
(-2.72%)
USD |
NASDAQ |
Dec 11, 16:00
82.18
-0.03
(-0.04%)
Pre-Market: 08:46
Inhibrx Biosciences Total Liabilities (Quarterly): 140.64M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 514.76M |
| Ligand Pharmaceuticals, Inc. | 526.60M |
| Armata Pharmaceuticals, Inc. | 185.10M |
| Adverum Biotechnologies, Inc. | 128.05M |
| Pelthos Therapeutics, Inc. | 68.18M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 177.47M |
| Shareholders Equity (Quarterly) | 36.83M |
| Debt to Equity Ratio | 2.903 |
| Current Ratio | 4.486 |
| Net Debt Paydown Yield | -4.30% |